Thrive Global launched a new mobile app geared to improve people's relationship with technology. The company's co-founder and CEO Arianna Huffington explains how it helps people combat their smartphone addiction.
Mozilla joining the fight to save net neutrality. The open source web browser filed a petition this week, challenging the Federal Communication Commission's vote to roll back Obama-era protections. Mozilla's Senior Policy Manager Heather West explains what the company is hoping to accomplish with this petition.
Amazon has selected a short-list of cities to be in the running to become the tech giants second headquarters. Digital Media Strategist John Boitnott shares his advice for these cities crafting their pitch to become the next hub for Amazon.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
